Skip to main content
BLINCYTO®▼ (blinatumomab) – Clarification of timing of premedication with dexamethasone in paediatric patients
For Healthcare Professionals
A potentially confusing statement which led to a translation issue has been discovered in the
Blincyto® Summary of Product Characteristic (SmPC) Section 4.2 regarding the second
administration of dexamethasone as premedication in paediatric patients
